Please enable Javascript
Conferences
Partners
Expert Interviews
Subscribe
Heme Today
Anemia
Deep Vein Thrombosis
Essential Thrombocythemia
Hemophilia
Immune Thrombocytopenic Purpura
Myelodysplastic Syndromes
Myelofibrosis
Myeloproliferative Neoplasms
PNH
Polycythemia Vera
Pulmonary Embolism
Sickle Cell Disease
Thrombocytopenia
Thrombophilia
Thrombosis
Thrombotic Thrombocytopenic Purpura
Venous Thromboembolism
von Willebrand Disease
Nephrology Times
Acute Kidney Injury
ADPKD
Anemia and Kidney Disease
Chronic Kidney Disease
COVID-19 and Kidney Disease
Diabetes and Hypertension
End-Stage Renal Disease
Gout
Hyperkalemia
IgAN
Kidney Transplantation
Metabolic Acidosis
Breast Cancers Today
HER2 Breast Cancer
HR Breast Cancer
Triple-Negative Breast Cancer
Genetics & Breast Cancer
Cardiology
Atherosclerotic Disease
Atrial Fibrillation
Heart Failure
Hypertension
Interventional Cardiology
Lipid Management
Practice Tips With Dr. Lichaa
Preventive Cardiology
Stroke
Oncology
Breast Cancer
Gynecologic Cancer
Head and Neck Cancer
Skin Cancer
Sleep
Urology
More
Diabetes
Ophthalmology
— Demodex Blepharitis
Neurology
Rheumatology
Gastroenterology
Pulmonology
Infectious Diseases
— HIV
Health and Wellness
Lupus
Future of Medicine
Orthopedics
Pharmacology
Career News
George Yaghmour, MD
George Yaghmour, MD, is from the
University of Southern California.
Articles by George Yaghmour, MD
ASH 2023 Data and Impacts on MDS Care: Molecular Markers, New Treatment Options, MRD
Guillermo Garcia-Manero, MD
MDS
|
February 8, 2024
The panel discusses forward-looking thoughts for the treatment of low-risk MDS.
View More
Can Early Transplant Be Used for Patients with Low-Risk MDS?
Guillermo Garcia-Manero, MD
MDS
|
February 8, 2024
The panel talks about the use of transplant for patients with low-risk myelodysplastic syndromes.
View More
Panel Discusses New Data on Emerging Therapies in MDS: Imetelstat, KER-050, and More
Guillermo Garcia-Manero, MD
MDS
|
February 8, 2024
The panel discusses other treatments undergoing research for MDS, including imetelstat and KER-050.
View More
Real-World Quality of Life, Patient Experience Associated with Luspatercept
Guillermo Garcia-Manero, MD
MDS
|
February 8, 2024
The panel shared their thoughts on real-world data of luspatercept presented at ASH 2023.
View More
What Do the Clinicians Say About Luspatercept?
Guillermo Garcia-Manero, MD
MDS
|
February 8, 2024
The panel addresses continued MDS research needs.
View More
Mutational Status, Comorbidities, MDS Treatment Selection
Guillermo Garcia-Manero, MD
MDS
|
February 8, 2024
The panel discusses appropriate treatment selection based on patient mutation status and comorbidities.
View More
Panel Reacts to Full Analysis of the COMMANDS Trial of Luspatercept for MDS
Guillermo Garcia-Manero, MD
MDS
|
February 8, 2024
The panel shares their thoughts on the full analysis of the COMMANDS study.
View More